About Medicago

Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and therapeutic proteins for infectious diseases and emerging public health challenges. Medicago’s technologies represent a game-changing approach to vaccine development and disease response. Unlike traditional pharmaceutical manufacturing, Medicago’s plant-based platform can more rapidly produce safe and effective vaccines and antibodies while also potentially providing broader and more sustained protection.

Therapeutic Areas

Infectious

Technologies

Vaccines

Company Type

Biotechnology – Diagnostics

State of Ownership

Private

Sponsorship Group

Networker

Popular Contributions

Topics

Editions participated in:

June 2018